Showing 1 - 10 of 5,236
Before it can sell a prescription drug lawfully in interstate commerce, a manufacturer must prove to the satisfaction … of the Food and Drug Administration that the drug is both safe and effective. Congress approved this requirement in 1962 … unanimously. Four decades of changes in the drug market have reshaped this regulatory hurdle. This article makes detailed …
Persistent link: https://www.econbiz.de/10014058315
by a PHO, prescriptions were restricted to a month's supply of the drug, and doses must be dispensed daily, under … benzodiazepines following the reform. To examine subsequent health, labor market, and drug abuse-related outcomes, I additionally … exploit regional variation in PHO strictness affecting the likelihood that addicts opt to quit the drug due to the reform. I …
Persistent link: https://www.econbiz.de/10012009659
associated with Food and Drug Administration (FDA)-mandated clinical trials of new drugs. But the relationship between the patent … system and other regulation of drugs is more complex than this simple formulation suggests. Drug regulation operates in … profitability by diverting profits elsewhere. At the same time, resistance to high drug prices is prompting new state and federal …
Persistent link: https://www.econbiz.de/10014126354
Persistent link: https://www.econbiz.de/10000584247
In the European Union, medicines are regulated products subject to both single market (e.g., regional exhaustion of property rights) and country specific health care regulations (e.g., medicines pricing). This gives rise to parallel trade (PT), a phenomenon that takes place when a patented...
Persistent link: https://www.econbiz.de/10010477153
Today, the global pharmaceutical product value chain is becoming increasingly complex and this has led to the emergence of 'multiple quality standards' for medicines. But this non-uniformity in the quality of medicine is also contingent upon both the regulatory milieu in the country of...
Persistent link: https://www.econbiz.de/10011337690
This paper uses macro-level data between 1997 and 2008 to evaluate the effects of China's pharmaceutical price regulations. We find that these regulations had short-run effects on medicine price indices, reducing them by less than 0.5 percentage points. The effects could have been slightly...
Persistent link: https://www.econbiz.de/10013066440
The paper uses a real option approach to investigate the impact of performance-based risk-sharing agreements for the reimbursement of new drugs in comparison with standard cost-effectiveness thresholds. The results show that the exact definition of the risk-sharing agreement is key in...
Persistent link: https://www.econbiz.de/10013078145
Before a new drug can be marketed the Food and Drug Administration must be satisfied that it is safe and effective … been advocated. This paper challenges the central argument in the debate on the topic, namely that drug regulation and drug … innovation are necessarily at odds with each other. Although intuitively appealing, the argument that drug regulation negatively …
Persistent link: https://www.econbiz.de/10012754003
This paper looks into various means of regulating pharmaceuticals and their effects on the structure of the … industry activities proceeds, national regulation aimed at reducing costs for pharmaceuticals can have the unintended effect of … leading to higher drug prices in the longer run, thereby compromising the original goal …
Persistent link: https://www.econbiz.de/10013127115